Literature DB >> 12000863

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.

Steven A Rosenberg1, Paul J Spiess, David E Kleiner.   

Abstract

Salmonella typhimurium genetically modified at the purI and msbB genes to increase dependence on adenine and decrease stimulation of tumor necrosis factor-alpha production were injected intravenously into C57BL/6 mice bearing subcutaneous tumor or lung metastases. Decreased tumor growth and prolonged survival were seen in some, but not all of nine transplantable tumors. Salmonella increased in number in the tumor and reached levels 10,000 times higher than in the normal liver reservoir of these bacteria. Histologic studies revealed Salmonella growth in areas of the tumor although, in all cases, a viable rim of tumor survived and ultimately resulted in progressive tumor growth in all mice. These studies demonstrate that Salmonella can localize to transplantable murine tumors and partially inhibit tumor growth; however, additional modifications of the bacteria may be necessary if this approach is to develop into an effective treatment for patients with cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12000863      PMCID: PMC2413432     

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  8 in total

1.  Replication-selective microbiological agents: fighting cancer with targeted germ warfare.

Authors:  D H Kirn
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Use of preferentially replicating bacteria for the treatment of cancer.

Authors:  M Sznol; S L Lin; D Bermudes; L M Zheng; I King
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

Authors:  C Clairmont; K C Lee; J Pike; M Ittensohn; K B Low; J Pawelek; D Bermudes; S M Brecher; D Margitich; J Turnier; Z Li; X Luo; I King; L M Zheng
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

4.  Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?

Authors:  D A Saltzman; E Katsanis; C P Heise; D E Hasz; V Vigdorovich; S M Kelly; R Curtiss; A S Leonard; P M Anderson
Journal:  J Pediatr Surg       Date:  1997-02       Impact factor: 2.545

5.  Tumor-targeted Salmonella as a novel anticancer vector.

Authors:  J M Pawelek; K B Low; D Bermudes
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

6.  Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

Authors:  John F Toso; Vee J Gill; Patrick Hwu; Francesco M Marincola; Nicholas P Restifo; Douglas J Schwartzentruber; Richard M Sherry; Suzanne L Topalian; James C Yang; Frida Stock; Linda J Freezer; Kathleen E Morton; Claudia Seipp; Leah Haworth; Sharon Mavroukakis; Donald White; Susan MacDonald; John Mao; Mario Sznol; Steven A Rosenberg
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

7.  Pulmonary metastases from autochthonous 3-methylcholanthrene-induced murine tumors.

Authors:  H Wexler; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1979-12       Impact factor: 13.506

8.  Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo.

Authors:  K B Low; M Ittensohn; T Le; J Platt; S Sodi; M Amoss; O Ash; E Carmichael; A Chakraborty; J Fischer; S L Lin; X Luo; S I Miller; L Zheng; I King; J M Pawelek; D Bermudes
Journal:  Nat Biotechnol       Date:  1999-01       Impact factor: 54.908

  8 in total
  20 in total

1.  Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.

Authors:  David C Binder; Boris Engels; Ainhoa Arina; Ping Yu; James M Slauch; Yang-Xin Fu; Theodore Karrison; Byron Burnette; Christian Idel; Ming Zhao; Robert M Hoffman; David H Munn; Donald A Rowley; Hans Schreiber
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

2.  Obligate anaerobic Salmonella typhimurium strain YB1 treatment on xenograft tumor in immunocompetent mouse model.

Authors:  Bin Yu; Lei Shi; Bao-Zhong Zhang; K E Zhang; Xiao Peng; Han-Ben Niu; Jun-LE Qu
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

3.  Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors.

Authors:  Nan Yang; Sheng-hua Li; Yun-zhe Lü; Li-shan Chen; Da-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

Review 4.  Engineering the perfect (bacterial) cancer therapy.

Authors:  Neil S Forbes
Journal:  Nat Rev Cancer       Date:  2010-10-14       Impact factor: 60.716

5.  Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.

Authors:  Edwin R Manuel; Céline A Blache; Rebecca Paquette; Teodora I Kaltcheva; Hidenobu Ishizaki; Joshua D I Ellenhorn; Michael Hensel; Leonid Metelitsa; Don J Diamond
Journal:  Cancer Res       Date:  2011-04-28       Impact factor: 12.701

6.  Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies.

Authors:  Michal Bereta; Andrew Hayhurst; Mariusz Gajda; Paulina Chorobik; Marta Targosz; Janusz Marcinkiewicz; Howard L Kaufman
Journal:  Vaccine       Date:  2007-03-22       Impact factor: 3.641

Review 7.  Engineering the gut microbiota to treat chronic diseases.

Authors:  Noura S Dosoky; Linda S May-Zhang; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2020-07-21       Impact factor: 4.813

8.  Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth.

Authors:  Markus Loeffler; Gaelle Le'Negrate; Maryla Krajewska; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

9.  IL-18-producing Salmonella inhibit tumor growth.

Authors:  M Loeffler; G Le'Negrate; M Krajewska; J C Reed
Journal:  Cancer Gene Ther       Date:  2008-07-25       Impact factor: 5.987

10.  The Boosting Potential of Bacteria in Cancer Immunotherapy.

Authors:  David C Binder; Derek A Wainwright
Journal:  Trends Mol Med       Date:  2017-06-02       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.